Literature DB >> 35418819

KMT2B-Related Dystonia: Challenges in Diagnosis and Treatment.

Ayşe Aksoy1, Özlem Yayıcı Köken2, Ahmet Cevdet Ceylan3, Özge Toptaş Dedeoğlu4.   

Abstract

In this study, we report the first known Turkish case of a novel nonsense mutation c.2453dupT (p.M818fs*28) in the KMT2B (NM_014727.2) gene diagnosed in a male patient with KMT2B-related dystonia (DYT-KMT2B, DYT-28, Dystonia*-28), which is a complex, childhood-onset, progressive, hereditary dystonia. The patient, who is followed up from 9 to 13 years of age, had dysmorphic features, developmental delay, short stature, and microcephaly, in addition to focal dystonia and hemichorea (in the right and left lower extremities). Generalized dystonia involving bulbar and cervical muscles, in addition to dystonic cramps, myoclonus, and hemiballismus, were also observed during the course of the follow-up. While he was able to perform basic functions like eating, climbing stairs, walking, and writing with the aid of levodopa and trihexyphenidyl treatment, his clinical status gradually deteriorated secondary to progressive generalized dystonia in the 4-year follow-up. Deep brain stimulation has been shown to be effective in several patients which could be the next preferred treatment for the patient.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Childhood dystonia; Exome sequencing; KMT2B; Movement disorder; Novel mutation

Year:  2021        PMID: 35418819      PMCID: PMC8928205          DOI: 10.1159/000518974

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  7 in total

Review 1.  Update on KMT2B-Related Dystonia.

Authors:  Michael Zech; Daniel D Lam; Juliane Winkelmann
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-25       Impact factor: 5.081

2.  Phenotype variability and allelic heterogeneity in KMT2B-Associated disease.

Authors:  Toshitaka Kawarai; Ryosuke Miyamoto; Eiji Nakagawa; Reiko Koichihara; Takashi Sakamoto; Hideo Mure; Ryoma Morigaki; Hidetaka Koizumi; Ryosuke Oki; Celeste Montecchiani; Carlo Caltagirone; Antonio Orlacchio; Ayako Hattori; Hideaki Mashimo; Yuishin Izumi; Takahiro Mezaki; Satoko Kumada; Makoto Taniguchi; Fusako Yokochi; Shinji Saitoh; Satoshi Goto; Ryuji Kaji
Journal:  Parkinsonism Relat Disord       Date:  2018-04-05       Impact factor: 4.891

3.  Clinical phenotypes, genotypes and treatment in Chinese dystonia patients with KMT2B variants.

Authors:  Xin-Yao Li; Li-Fang Dai; Xin-Hua Wan; Yi Guo; Yi Dai; Shang-Lin Li; Fang Fang; Xiao-Hui Wang; Wei-Hua Zhang; Ting-Hong Liu; Zi-Hang Xie; Tie Fang; Lin Wang; Chang-Hong Ding
Journal:  Parkinsonism Relat Disord       Date:  2020-06-09       Impact factor: 4.891

4.  Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia.

Authors:  Michael Zech; Sylvia Boesch; Esther M Maier; Ingo Borggraefe; Katharina Vill; Franco Laccone; Veronika Pilshofer; Andres Ceballos-Baumann; Bader Alhaddad; Riccardo Berutti; Werner Poewe; Tobias B Haack; Bernhard Haslinger; Tim M Strom; Juliane Winkelmann
Journal:  Am J Hum Genet       Date:  2016-11-10       Impact factor: 11.025

5.  Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single-center cohort study.

Authors:  Miryam Carecchio; Federica Invernizzi; Paulina Gonzàlez-Latapi; Celeste Panteghini; Giovanna Zorzi; Luigi Romito; Vincenzo Leuzzi; Serena Galosi; Chiara Reale; Federica Zibordi; Agnel P Joseph; Maya Topf; Carla Piano; Anna Rita Bentivoglio; Floriano Girotti; Paolo Morana; Benedetto Morana; Manju A Kurian; Barbara Garavaglia; Niccolò E Mencacci; Steven J Lubbe; Nardo Nardocci
Journal:  Mov Disord       Date:  2019-06-19       Impact factor: 10.338

6.  KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.

Authors:  Laura Cif; Diane Demailly; Jean-Pierre Lin; Katy E Barwick; Mario Sa; Lucia Abela; Sony Malhotra; Wui K Chong; Dora Steel; Alba Sanchis-Juan; Adeline Ngoh; Natalie Trump; Esther Meyer; Xavier Vasques; Julia Rankin; Meredith W Allain; Carolyn D Applegate; Sanaz Attaripour Isfahani; Julien Baleine; Bettina Balint; Jennifer A Bassetti; Emma L Baple; Kailash P Bhatia; Catherine Blanchet; Lydie Burglen; Gilles Cambonie; Emilie Chan Seng; Sandra Chantot Bastaraud; Fabienne Cyprien; Christine Coubes; Vincent d'Hardemare; Asif Doja; Nathalie Dorison; Diane Doummar; Marisela E Dy-Hollins; Ellyn Farrelly; David R Fitzpatrick; Conor Fearon; Elizabeth L Fieg; Brent L Fogel; Eva B Forman; Rachel G Fox; William A Gahl; Serena Galosi; Victoria Gonzalez; Tracey D Graves; Allison Gregory; Mark Hallett; Harutomo Hasegawa; Susan J Hayflick; Ada Hamosh; Marie Hully; Sandra Jansen; Suh Young Jeong; Joel B Krier; Sidney Krystal; Kishore R Kumar; Chloé Laurencin; Hane Lee; Gaetan Lesca; Laurence Lion François; Timothy Lynch; Neil Mahant; Julian A Martinez-Agosto; Christophe Milesi; Kelly A Mills; Michel Mondain; Hugo Morales-Briceno; John R Ostergaard; Swasti Pal; Juan C Pallais; Frédérique Pavillard; Pierre-Francois Perrigault; Andrea K Petersen; Gustavo Polo; Gaetan Poulen; Tuula Rinne; Thomas Roujeau; Caleb Rogers; Agathe Roubertie; Michelle Sahagian; Elise Schaefer; Laila Selim; Richard Selway; Nutan Sharma; Rebecca Signer; Ariane G Soldatos; David A Stevenson; Fiona Stewart; Michel Tchan; Ishwar C Verma; Bert B A de Vries; Jenny L Wilson; Derek A Wong; Raghda Zaitoun; Dolly Zhen; Anna Znaczko; Russell C Dale; Claudio M de Gusmão; Jennifer Friedman; Victor S C Fung; Mary D King; Shekeeb S Mohammad; Luis Rohena; Jeff L Waugh; Camilo Toro; F Lucy Raymond; Maya Topf; Philippe Coubes; Kathleen M Gorman; Manju A Kurian
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

7.  KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes.

Authors:  Giulia Barbagiovanni; Pierre-Luc Germain; Michael Zech; Sina Atashpaz; Pietro Lo Riso; Agnieszka D'Antonio-Chronowska; Erika Tenderini; Massimiliano Caiazzo; Sylvia Boesch; Robert Jech; Bernhard Haslinger; Vania Broccoli; Adrian Francis Stewart; Juliane Winkelmann; Giuseppe Testa
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.